0
0
General
Fintel reports that on Can also 10, 2023, Craig-Hallum upgraded their outlook for Precise Sciences (NASDAQ:EXAS) from Preserve to Purchase .
Analyst Trace Forecast Suggests 9.61% Upside
As of April 24, 2023, the typical one-300 and sixty five days brand target for Precise Sciences is 77.82. The forecasts fluctuate from a low of 55.55 to a high of $ninety nine.75. The usual brand target represents an lengthen of 9.61% from its most unusual reported closing brand of 71.00.
Perceive our leaderboard of companies with the most well-known brand target upside.
The projected annual earnings for Precise Sciences is 2,322MM, an lengthen of 5.54%. The projected annual non-GAAP EPS is -2.69.
What’s the Fund Sentiment?
There are 1080 funds or institutions reporting positions in Precise Sciences. That is an lengthen of 108 owner(s) or 11.11% in the final quarter. Moderate portfolio weight of all funds dedicated to EXAS is 0.25%, an lengthen of 37.63%. Total shares owned by institutions reduced in the final three months by 3.57% to 198,198K shares. 
The put/call ratio of EXAS is 0.Seventy nine, indicating a bullish outlook.
What are Other Shareholders Doing?
ARK Funding Management holds 11,379K shares representing 6.33% possession of the firm. In or no longer it’s prior filing, the company reported owning 16,040K shares, representing a decrease of 40.96%. The company reduced its portfolio allocation in EXAS by 22.94% over the previous quarter.
Wellington Management Neighborhood Llp holds 10,252K shares representing 5.70% possession of the firm. In or no longer it’s prior filing, the company reported owning 11,228K shares, representing a decrease of 9.52%. The company increased its portfolio allocation in EXAS by 30.ninety nine% over the previous quarter.
ARKK – ARK Innovation ETF holds 8,818K shares representing 4.90% possession of the firm. In or no longer it’s prior filing, the company reported owning 11,226K shares, representing a decrease of 27.31%. The company increased its portfolio allocation in EXAS by 52.69% over the previous quarter.
Jpmorgan Scramble holds 7,750K shares representing 4.31% possession of the firm. In or no longer it’s prior filing, the company reported owning 4,634K shares, representing an lengthen of 40.20%. The company increased its portfolio allocation in EXAS by 133.93% over the previous quarter.
VTSMX – Forefront Total Stock Market Index Fund Investor Shares holds 5,409K shares representing 3.01% possession of the firm. In or no longer it’s prior filing, the company reported owning 5,271K shares, representing an lengthen of 2.56%. The company increased its portfolio allocation in EXAS by 44.43% over the previous quarter.
Precise Sciences Background Data
(This description is supplied by the firm.)
A leading provider of most cancers screening and diagnostic assessments, Precise Sciences relentlessly pursues smarter solutions providing the clarity to grab existence-altering action, earlier. Constructing on the success of Cologuard and Oncotype DX, Precise Sciences is investing in its product pipeline to grab on one of the most deadliest cancers and toughen patient care. Precise Sciences unites visionary collaborators to again reach the fight in opposition to most cancers.
Perceive all Precise Sciences regulatory filings.
This fable before the entire lot looked on Fintel.
The views and opinions expressed herein are the views and opinions of the author and draw no longer necessarily mirror these of Nasdaq, Inc.
